Long-term survival following treatment with antineoplastons for colon cancer with unresectable multiple liver metastases: Report of a case

Surgery Today

Volumn 33, Issue 6, 2003, Pages 448-453

  Ogata, Yutaka ^a   Tsuda, Hideaki ^a   Matono, Keiko ^a   Kumabe, Tsutomu ^a   Saitsu, Hideki ^a   Hara, Hiroshi ^a   Akagi, Yoshito ^a   Araki, Yasumi ^a   Sata, Michio ^a   Shirouzu, Kazuo ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

A10; Antineoplaston; AS2 1; Colon cancer; Liver metastasis; Microwave coagulation necrosis therapy

Indexed keywords

3 PHENYLACETAMIDO 2,6 PIPERIDINEDIONE; ANTINEOPLASTON AS2-1; CARCINOEMBRYONIC ANTIGEN; PROTEIN P21; PROTEIN P53; UFT;

ABDOMINAL DISCOMFORT; AGED; ARTICLE; CANCER SURVIVAL; CASE REPORT; COLON ADENOCARCINOMA; HEMICOLECTOMY; HUMAN; HUMAN TISSUE; LIVER METASTASIS; MALE; MICROWAVE IRRADIATION; PRURITUS; SIDE EFFECT; STOMACH DISEASE; TREATMENT OUTCOME;

ADENOCARCINOMA; AGED; BENZENEACETAMIDES; COLECTOMY; COLONIC NEOPLASMS; COMBINED MODALITY THERAPY; ELECTROCOAGULATION; HUMANS; LIVER NEOPLASMS; MALE; MICROWAVES; PIPERIDONES; PROGNOSIS; SURVIVORS;

EID: 0038359441     PISSN: 09411291     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10595-002-2503-2     Document Type: Article

References (21)

1. Taylor M, Forster J, Langer B, Taylor BR, Greig PD, Mahut C. A study of prognostic factors for hepatic resection for colorectal metastases. Am J Surg 1997;173:467-71.
2. Fong Y, Salo J. Surgical therapy of hepatic colorectal metastasis. Semin Oncol 1999;26:514-23.
3. Bolton JS, Fuhrman GM. Survival after resection of multiple bilobar hepatic metastases from colorectal carcinoma. Ann Surg 2000;231:743-51.
4. Wagner JS, Adson MA, Heedon JA. The natural history of hepatic metastases from colorectal cancer. Ann Surg 1984;199:504-9.
5. Ambiru S, Miyazaki M, Isono T, Ito H, Nakagawa K, Shimizu H, et al. Hepatic resection for colorectal metastases: analysis of prognostic factors. Dis Colon Rectum 1999;42:632-9.
6. Burzynski SR. Antineoplastons: biochemical defense against cancer. Physiol Chem Phys 1976;8:275-9.
7. Burzynski SR, Mohabbat MO, Burzynski B. Human toxicology studies on oral formulation of antineoplaston A10. Drugs Exp Clin Res 1984;10:891-5.
8. Tsuda H, Hara H, Eriguchi N, Nishida H, Yoshida H, Kumabe T, Sugita Y. Toxicological study on antineoplastons A10 and AS2-1 in cancer patients. Kurume Med J 1995;42:241-6.
9. Tsuda H, Iemura A, Sata M, Uchida M, Yamana K, Hara H. Inhibitory effect of antineoplastons A10 and AS2-1 on human hepatocellular carcinoma. Kurume Med J 1996;43:137-47.
10. Holbrook NJ, Fornace A Jr. Response to adversity: molecular control of gene activation following genotoxic stress. New Biol 1991;3:825-33.
11. Fornace A Jr. Mammalian genes induced by radiation: activation of genes associated with growth control. Annu Rev Genet 1992; 26:507-26.
12. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Craig RW. Participation of p53 protein in cellular response to DNA damage. Cancer Res 1991;51:6304-11.
13. Lane DP. p53, guardian of the genome. Nature 1992;385:15-16.
14. Hollstein M, Sidranski D, Vogelstein B, Harris CC. p53 mutations in human cancer. Science 1991;253:49-53.
15. Bykov VJ, Issaeva N, Shilov A, Hultcrantz M, Pugacheva E, Chumakov P, et al. Restoration of the tumor suppressor function to mutant p53 by a low-molecular-weight compound. Nat Med 2002,8:282-8.
16. Castillo M, Iglesias J, Zafra MF, Garcia-Peregrin E. Inhibition of chick brain cholesterogenic enzymes by phenyl and phenolic derivatives of phenylalanine. Neurochem Res 1991;18:171-4.
17. Samid D, Yeh TJ, Shack S. Interferon in combination with antitumorigenic phenyl derivatives: potentiation of α-INF activity in vitro. Br J Haematol 1991;79(suppl 1):81-3.
18. Tsuda H, Sugihara S, Nishida H, Hara H, Eriguchi N, Ishii K, et al. The inhibitory effect of the combination of antineoplaston A10 injection with a small dose of cis-diamminedichloroplatinum on cell and tumor growth of human hepatocellular carcinoma. Jpn J Cancer Res 1992;83:527-31.
19. Seki T, Wakabayashi M, Nakagawa T, Imamura M, Tamai T, Nishimura A, et al. Percutaneous microwave coagulation therapy for solitary metastatic tumor from colorectal cancer: a pilot clinical study. Am J Gastroenterol 1999;94:322-7.
20. Badria F, Mabed M, Khafagy W, Abou-Zeid L. Potential utility of antineoplaston A-10 level in breast cancer. Cancer Lett 2000; 155:67-70.
21. Liau MC, Lee SS, Burzynski SR. Hypomethylation of nucleic acids: a key to the induction of terminal differentiation. Int J Exp Clin Chemother 1989;2:187-99.